# Myo-inositol Versus Clomiphene Citrate in PCOS

> **NCT04306692** · PHASE4 · TERMINATED · sponsor: **University Hospital, Ghent** · enrollment: 12 (actual)

## Conditions studied

- Ovulation Induction
- Polycystic Ovary Syndrome
- Clomiphene
- Inositol

## Interventions

- **DRUG:** Myo-inositol
- **DRUG:** Clomiphene Citrate

## Key facts

- **NCT ID:** NCT04306692
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-07-02
- **Primary completion:** 2021-04-20
- **Final completion:** 2022-01-31
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** clomiphene citrate is no longer being considered as standard treatment for polycystic ovary syndrome
- **Last updated:** 2022-12-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04306692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04306692, "Myo-inositol Versus Clomiphene Citrate in PCOS". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04306692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*